Drug Topics

SEPTEMBER 18, 2023

From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.

Medication Dispensing 247

Medication Dispensing 247

STAT

SEPTEMBER 18, 2023

In the wake of growing alarm over the disproportionately high rates of maternal mortality in the U.S., maternal health experts have been pushing for changes — including expanding the midwife workforce. Studies have shown that deliveries attended by midwives tend to have fewer complications and better outcomes, partially because midwife training relies less on medical intervention, leading to fewer C-sections.

Hospitals 145

Hospitals 145

Drug Topics

SEPTEMBER 18, 2023

The 3 most common issues associated with higher satisfaction were “makes adjusting insulin easier,” “helps to keep low blood sugars from happening,” and “makes me feel safer knowing that I will be warned about low blood sugar before it happens.

112

112

STAT

SEPTEMBER 18, 2023

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned. The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with k

144

144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

SEPTEMBER 18, 2023

NEW YORK CITY—Advances in technology innovation and artificial intelligence can help accelerate global sustainable development efforts to combat hunger, poverty and climate change and improve healt | Advances in technology innovation and artificial intelligence can help accelerate global sustainable development efforts to combat hunger, poverty and climate change and improve health outcomes, a United Nations official said Monday.

134

134

STAT

SEPTEMBER 18, 2023

Comments to antitrust regulators lay bare Americans’ anger and disillusionment over consolidation’s effects on all sectors of the economy, but especially health care. A 24-year-old wrote that after his hometown hospital in Indiana merged with a bigger group, his mom, who worked there, found it harder to provide good care amid staff cuts and reduced support.

Hospitals 138

Hospitals Insurance 138

STAT

SEPTEMBER 18, 2023

The era of rampant, unconsented, and unregulated online data collection may finally be winding down for consumer health data. But the advances in consumer privacy have not yet fully reached the millions of people with health information related to their drug use, substance use disorder treatment, or recovery. In July, two key agencies for consumer health privacy, the Department of Health and Human Services and the Federal Trade Commission, sent  letters  to 130

Hospitals 131

Hospitals 131

Drug Topics

SEPTEMBER 18, 2023

Investigators saw there was a significant difference of lower treatment initiation in people younger than 30 years old, females, Hispanic and Asian individuals, and people who inject drugs.

98

98

STAT

SEPTEMBER 18, 2023

Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals. Medicare has admitted it is doing so due to an error in reading federal law, but it also goes against the grain of the current environment, where support for site-neutral payments has never been higher. Some members of Congress and health care experts are pushing for a system that would not pay hospital outpatient departments more for identical services that are prov

Hospitals 129

Hospitals Insurance 129

Drug Topics

SEPTEMBER 18, 2023

Implementing a standardized oxytocin infusion protocol may increase patient safety while reducing maternal adverse effects that are associated with rapid, high rates of infusion of oxytocin.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

SEPTEMBER 18, 2023

With the loss of elasticity in the skin that accompanies aging, platysma bands can become more apparent, protruding from the neck. | Already approved as an injection to reduce wrinkles in the forehead and around the eyes, AbbVie's Botox is in position to expand its cosmetic uses to the moderate to severe form of platysma prominence, a condition which causes muscle bands to protrude from the neck.

121

121

Pharmacy Times

SEPTEMBER 18, 2023

Most patients with myelofibrosis will develop anemia over the course of the disease, with more than 30% discontinuing treatment as a result.

FDA 122

FDA 122

Fierce Pharma

SEPTEMBER 18, 2023

Amid Sanofi’s multi-year effort to simplify its product portfolio, the drugmaker is offloading 11 central nervous system (CNS) meds to lifecycle management company Pharmanovia. | The move falls in line with CEO Paul Hudson's mission to focus Sanofi's efforts on "best-in-class" growth drivers, including the immunology superstar Dupixent.

118

118

Drug Store News

SEPTEMBER 18, 2023

Megan Timberlake, Senior Vice President – P&G, Walmart Sales & North America Sustainability Leader, discusses the role sustainability plays in how consumers choose what products they purchase.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

SEPTEMBER 18, 2023

With backing from an FDA advisory committee and results from a positive phase 3 trial, respectively, Alnylam and BridgeBio are each on track to enter the blockbuster transthyretin amyloidosis cardi | Alnylam and BridgeBio are each on track to enter the blockbuster transthyretin amyloidosis cardiomyopathy (ATTR-CM) market. But doctors say they'll mostly stick with Pfizer's first-to-market offerings.

FDA 115

FDA 115

The Checkup by Singlecare

SEPTEMBER 18, 2023

During pregnancy, your body’s need for nutrients like iron, folate, and vitamin B12 increases significantly, and it can be difficult to keep up. When those needs aren’t met, you can develop a mild case of anemia in pregnancy, which is fairly common among pregnant people. In some cases, though, anemia in pregnancy can become severe and put your developing baby at risk.

Health and Personal Care Stores 111

Health and Personal Care Stores Mayo Clinic Immunization FDA 111

Fierce Pharma

SEPTEMBER 18, 2023

Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time, the exec is jumping ship to U.S. | Catalent has named Lonza’s David McErlane group president of its biologics segment. Lonza is losing its bioscience business head just as CEO Pierre-Alain Ruffieux is stepping down.

114

114

Pharmacy Times

SEPTEMBER 18, 2023

Strategies include improving compliance, convenience, symptom management, and reducing stigma around pre-exposure prophylaxis for HIV.

121

121

Fierce Pharma

SEPTEMBER 18, 2023

After inking and expanding a biosimilar production partnership with Pfizer this summer, Korea’s Samsung Biologics is boosting yet another Big Pharma manufacturing agreement. | Samsung Biologics has inked a new deal with Bristol Myers Squibb for large-scale drug substance production on an unnamed commercial cancer antibody. The partners have already been working together on antibody manufacturing and have expanded their relationship over time.

112

112

Drug Store News

SEPTEMBER 18, 2023

The Radiant X body care line features ingredients typically used on products for the face and targets such needs as moisture imbalance, dark spots and uneven skin tone.

105

105

European Pharmaceutical Review

SEPTEMBER 18, 2023

The Cell and Gene Therapy Catapult (CGT Catapult) , supported by Scotland’s national economic development agency, Scottish Enterprise, has launched a new cooperative network to foster collaboration and increase knowledge sharing across the Advanced Therapy Medicinal Products (ATMP) industry in Scotland. Events, as well as talks from industry leaders and networking opportunities, will be coordinated by a new ‘Scottish Advanced Therapy Medicinal Products (ATMP) and Vaccines Network’ to aid individ

Vaccines 102

Vaccines 102

PharmaVoice

SEPTEMBER 18, 2023

An effort to spare the species from blood collection is one of many ways the industry is turning away from animals for R&D.

121

121

STAT

SEPTEMBER 18, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was restful and invigorating because now that familiar routine of meetings and deadlines and what-not has returned. As you might expect, we are coping by quaffing a few cups of welcome stimulation — our flavor today is southern pecan — and, as always, we invite you to join us.

Packaging 91

Packaging 91

Drug Store News

SEPTEMBER 18, 2023

The challenge supports non-profit organizations whose work has a direct impact on creating a future that promotes healthier people and a healthier planet.

105

105

Fierce Healthcare

SEPTEMBER 18, 2023

Recent survey data from The Physicians Foundation suggest residents and medical students are no strangers to the widespread burnout weighing down America’s physician workforce. | Medical students—and, in some cases, residents—more frequently reported mental health difficulties than practicing physicians, among whom feelings of burnout remain well above pre-pandemic rates.

103

103

Outsourcing Pharma

SEPTEMBER 18, 2023

The French-U.S. company Novadiscovery has hailed a âwatershed moment for clinical trial designâ as its trial simulation tool successfully predicted the outcome of a phase 3 oncology trial run by AstraZeneca.

95

95

Drug Store News

SEPTEMBER 18, 2023

Ice Breakers Raspberry Lemon Seltzer Sparkling Mints contain a bubbly fizz that is reminiscent of sipping on flavored seltzer, the company said.

105

105

Pharmaceutical Technology

SEPTEMBER 18, 2023

Embattled biotech giant Illumina has led series A funding into genomics mapping company Broken String Biosciences.

116

116

Fierce Healthcare

SEPTEMBER 18, 2023

Collaboration, communication and controlling costs: How one tool is modernizing the way the dental industry does business jpiatt Mon, 09/18/2023 - 15:52

Communication 98

Communication 98

European Pharmaceutical Review

SEPTEMBER 18, 2023

The first and only treatment for anaemic patients with myelofibrosis has been approved by the US Food and Drug Administration (FDA). Ojjaara (momelotinib) is indicated for intermediate or high-risk myelofibrosis, a blood cancer, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anaemia.

FDA 89

FDA 89

Pharmaceutical Technology

SEPTEMBER 18, 2023

The FDA released a draft guidance giving advice on the correct labelling of biosimilar and interchangeable biosimilar products.

Labelling 105

Labelling FDA 105

Pharmacy Times

SEPTEMBER 18, 2023

In this episode of Pharmacy Focus: Student Edition, we dive deep into the world of scholarship funds from Good Neighbor Pharmacy and Cencora, designed to support Black student pharmacists.

81

81

European Pharmaceutical Review

SEPTEMBER 18, 2023

The European Medicines Agency (EMA)’s human medicines committee (CHMP) recommended nine new medicines for approval during its meeting in September 2023. The committee recommended granting a marketing authorisation for Ebglyss (lebrikizumab). This medicine is indicated for treating moderate-to-severe atopic dermatitis in adults and adolescents. To treat glioma, a type of brain tumour, the CHMP gave a positive opinion for Finlee (dabrafenib).

Vaccines 86

Vaccines 86

Pharmaceutical Technology

SEPTEMBER 18, 2023

Despite major shifts in the IBD landscape, most approaches that go beyond targeting inflammation remain in the earlier stages of development.

98

98